Browse Category

Solutions - Page 17

New Medical Solutions curates credible advances that solve real problems in healthcare—faster diagnosis, safer procedures, better monitoring, smoother coordination, and fairer access.

Cambrex to drop $120M to expand US operations amid industry’s breakneck onshoring drive

Cambrex revealed plans to spend $120 million to expand its Iowa manufacturing operations on the heels of a report last month that its owner was seeking a sale.

October 23, 2025

News·Solutions

FDA cites Nephron again for ongoing issues the generics manufacturer has failed to resolve

Nephron Pharmaceuticals’ manufacturing facility in West Columbia, South Carolina, is still running afoul of the FDA. In its most recent Form 483 report, the agency has cited several problems that were evident

October 22, 2025

News·Solutions

Merck KGaA to mothball operations at Ireland API plant by end of 2028

Merck KGaA plans to discontinue operations at its production plant in Arklow, Ireland, “by the end of 2028,” a company spokesperson confirmed to Fierce Pharma. The decision follows a strategic review of

October 22, 2025

News·Solutions

Wilmington PharmaTech, on mission to boost US drug ingredient capacity, snares investment from PE firm Curewell

Private equity firm Curewell Capital is aiming to close the gap in U.S. API production with a majority investment in specialty CDMO Wilmington PharmaTech.

October 21, 2025

News·Solutions

India’s ACG pumps $200M into its first US empty-capsule production facility

ACG, a supplier for solid dose drug manufacturers, is pumping $200 million into what will be the India-based company’s first empty-capsule production facility in the U.S.

October 21, 2025

News·Solutions

Merck grows again in Va. with $3B small-molecule drug plant, part of planned $70B US outlay

The investment is part of the New Jersey company’s plan to spend more than $70 billion on manufacturing, R&D and capital projects in the U.S. starting this year.

October 20, 2025

News·Solutions

AstraZeneca to spend $445M to boost production of Lokelma at Texas plant

With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia treatment with a $445 million injection of funds. The investment will increase the capabilities of AZ’s

October 15, 2025

News·Solutions

Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis

In addition to substantial spray drying capacity, new CDMO Codis says it’s also equipped to handle commercial-scale work on amorphous solid dispersions, particle engineering and finished dose manufacturing for pharma, consumer health

October 15, 2025

News·Solutions

Disruptive Innovation in MedTech: Evolving Characteristics and Modern Realities

Disruptive innovation has long driven paradigm shifts in medical devices, transforming care delivery, access, and outcomes. In 2025, the bar now includes demonstrated clinical performance, workflow re-engineering, reimbursement alignment, and real-world evidence

October 15, 2025

Solutions

BioNTech’s African mRNA vaccine production push gets EU funding boost

As BioNTech works to establish a production footprint for mRNA vaccines in Africa, two EU groups have offered financial backing to the company’s efforts.

October 14, 2025

News·Solutions

Previous 1 … 15 16 17 18 19 20 Next

Go toTop